ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2015/01/30 | 1,931 | 1,936 | 1,909 | 1,920 | +19 | +1% | 85,200 |
2015/01/29 | 1,984 | 1,997 | 1,901 | 1,901 | -87 | -4.4% | 291,800 |
2015/01/28 | 1,988 | 1,995 | 1,974 | 1,988 | +3 | +0.2% | 128,000 |
2015/01/27 | 1,957 | 1,986 | 1,951 | 1,985 | +28 | +1.4% | 116,900 |
2015/01/26 | 1,884 | 1,959 | 1,883 | 1,957 | +73 | +3.9% | 181,300 |
2015/01/23 | 1,932 | 1,934 | 1,876 | 1,884 | -27 | -1.4% | 245,500 |
2015/01/22 | 1,920 | 1,922 | 1,904 | 1,911 | -4 | -0.2% | 140,900 |
2015/01/21 | 1,960 | 1,964 | 1,913 | 1,915 | -25 | -1.3% | 115,700 |
2015/01/20 | 1,919 | 1,940 | 1,906 | 1,940 | +20 | +1% | 122,600 |
2015/01/19 | 1,935 | 1,941 | 1,914 | 1,920 | -15 | -0.8% | 104,000 |
2015/01/16 | 1,955 | 1,959 | 1,911 | 1,935 | -40 | -2% | 151,700 |
2015/01/15 | 1,955 | 1,982 | 1,954 | 1,975 | +20 | +1% | 73,100 |
2015/01/14 | 1,963 | 1,976 | 1,953 | 1,955 | -16 | -0.8% | 55,400 |
2015/01/13 | 1,979 | 1,996 | 1,953 | 1,971 | -30 | -1.5% | 88,500 |
2015/01/09 | 2,018 | 2,028 | 1,994 | 2,001 | -16 | -0.8% | 47,600 |
2015/01/08 | 1,969 | 2,020 | 1,969 | 2,017 | +57 | +2.9% | 47,400 |
2015/01/07 | 1,961 | 1,987 | 1,960 | 1,960 | -6 | -0.3% | 50,400 |
2015/01/06 | 2,014 | 2,025 | 1,966 | 1,966 | -64 | -3.2% | 107,900 |
2015/01/05 | 2,014 | 2,050 | 2,005 | 2,030 | +16 | +0.8% | 63,700 |
2014/12/30 | 2,030 | 2,039 | 2,014 | 2,014 | -16 | -0.8% | 48,100 |
2014/12/29 | 2,036 | 2,042 | 2,003 | 2,030 | -4 | -0.2% | 89,600 |
2014/12/26 | 2,039 | 2,043 | 2,027 | 2,034 | +6 | +0.3% | 63,900 |
2014/12/25 | 2,040 | 2,042 | 2,024 | 2,028 | -6 | -0.3% | 58,900 |
2014/12/24 | 2,040 | 2,043 | 2,018 | 2,034 | +4 | +0.2% | 94,700 |
2014/12/22 | 2,040 | 2,043 | 2,018 | 2,030 | ±0 | ±0% | 65,500 |
2014/12/19 | 2,023 | 2,039 | 2,017 | 2,030 | +39 | +2% | 131,700 |
2014/12/18 | 1,987 | 2,009 | 1,977 | 1,991 | +35 | +1.8% | 75,900 |
2014/12/17 | 1,945 | 2,000 | 1,935 | 1,956 | +10 | +0.5% | 127,100 |
2014/12/16 | 1,980 | 1,996 | 1,945 | 1,946 | -72 | -3.6% | 112,900 |
2014/12/15 | 1,980 | 2,038 | 1,968 | 2,018 | +40 | +2% | 163,100 |
2014/12/12 | 1,959 | 1,990 | 1,959 | 1,978 | +9 | +0.5% | 169,600 |
2014/12/11 | 1,967 | 1,981 | 1,955 | 1,969 | +2 | +0.1% | 270,100 |
2014/12/10 | 1,990 | 1,991 | 1,965 | 1,967 | -25 | -1.3% | 124,700 |
2014/12/09 | 1,995 | 2,005 | 1,990 | 1,992 | -9 | -0.4% | 65,500 |
2014/12/08 | 1,986 | 2,017 | 1,986 | 2,001 | -34 | -1.7% | 177,200 |
2014/12/05 | 2,030 | 2,038 | 2,013 | 2,035 | +3 | +0.1% | 141,800 |
2014/12/04 | 2,050 | 2,054 | 2,025 | 2,032 | +15 | +0.7% | 148,500 |
2014/12/03 | 2,040 | 2,042 | 2,003 | 2,017 | +3 | +0.1% | 125,500 |
2014/12/02 | 1,974 | 2,015 | 1,972 | 2,014 | +42 | +2.1% | 136,100 |
2014/12/01 | 1,969 | 1,995 | 1,968 | 1,972 | +15 | +0.8% | 135,700 |
2014/11/28 | 1,942 | 1,962 | 1,939 | 1,957 | +35 | +1.8% | 139,400 |
2014/11/27 | 1,927 | 1,933 | 1,920 | 1,922 | -4 | -0.2% | 142,700 |
2014/11/26 | 1,920 | 1,944 | 1,920 | 1,926 | +6 | +0.3% | 176,900 |
2014/11/25 | 1,955 | 1,955 | 1,920 | 1,920 | -20 | -1% | 317,100 |
2014/11/21 | 1,952 | 1,954 | 1,925 | 1,940 | -9 | -0.5% | 174,300 |
2014/11/20 | 1,960 | 1,962 | 1,940 | 1,949 | -10 | -0.5% | 130,600 |
2014/11/19 | 1,970 | 1,984 | 1,956 | 1,959 | -2 | -0.1% | 107,000 |
2014/11/18 | 1,951 | 1,985 | 1,951 | 1,961 | +9 | +0.5% | 159,200 |
2014/11/17 | 2,006 | 2,013 | 1,940 | 1,952 | -51 | -2.5% | 328,400 |
2014/11/14 | 2,018 | 2,018 | 1,994 | 2,003 | +9 | +0.5% | 225,600 |
2401~
2450
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム